Claritev Partners with Fractional AI to Accelerate Responsible GenAI Adoption in Healthcare

Fractional AI, a leading provider of bespoke generative AI solutions, announced a new collaboration with Claritev, formerly known as MultiPlan. This coll...

June 26, 2025 | Thursday | News
Perceptive Discovery Launches FIBRE Consortium with Pfizer, Lantheus, and Lumina to Advance Imaging Biomarkers in Fibrotic Diseases

Perceptive Discovery, a global leader in molecular and functional imaging research, today announced the launch of the FIBRE (Fibrosis Imaging Biomarker R...

June 23, 2025 | Monday | News
Yale School of Medicine Launches Biomedical Imaging Institute to Drive Innovation in Health and Disease Research

Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that will unite leading experts in ...

June 23, 2025 | Monday | News
NeuralCure AI Launches First Diagnostic & Digital Twin OS to Power Patient-Led Healthcare Revolution

NeuralCure AI  announced the official launch of its groundbreaking Diagnostic & Digital Twin Operating System, the first infrastructure platform...

June 20, 2025 | Friday | News
Chiesi Group and Key2Brain Expand Collaboration to Advance BBB-Crossing Therapies for Ultra-Rare Lysosomal Storage Disorders

Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disor...

June 12, 2025 | Thursday | News
MIT, Recursion, and NVIDIA Launch Boltz-2: Open-Source AI Model Sets New Standard for Binding Affinity Prediction

Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free...

June 09, 2025 | Monday | News
Augustine Therapeutics Doses First Patient in Phase I Trial of Novel HDAC6 Inhibitor for Charcot-Marie-Tooth Disease

Augustine Therapeutics NV (“Augustine” or “the Company”), a biotechnology company focused on developing new therapies for neuromu...

May 28, 2025 | Wednesday | News
Sanofi Opens $130M U.S. Flagship Office in Morristown to Drive Innovation, Collaboration, and Community Impact

Sanofi  announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration...

May 23, 2025 | Friday | News
Silo Pharma Partners with Resyca for Nasal Spray Device Study to Advance PTSD Treatment SPC-15

Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel ther...

May 22, 2025 | Thursday | News
Qosina Partners with Sealed Air to Expand Bioprocessing Portfolio with NEXCEL® BIO1250 High-Performance Bag Film

Qosina, a global leader in the distribution of single-use medical and biopharmaceutical components, is proud to announce a new strategic partnership with...

May 09, 2025 | Friday | News
Lantheus to Divest SPECT Business to SHINE Technologies Parent, Illuminated Holdings, in Strategic Refocus on PET and Radiopharmaceutical Innovation

Lantheus Holdings, Inc.the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better ...

May 07, 2025 | Wednesday | News
Stablepharma Doses First Participant in Phase 1 Trial of Fridge-Free Tetanus and Diphtheria Vaccine, SPVX02

 Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheri...

April 29, 2025 | Tuesday | News
ImmVira Presents Promising Phase I Results for Oncolytic HSV Therapy MVR-C5252 in Recurrent Malignant Glioma at AACR 2025

From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-...

April 28, 2025 | Monday | News
Debiopharm and Oncodesign Services Partner to Advance Preclinical Radioimmunotherapy Using AbYlink™ Bioconjugation Technology

Debiopharm Research & Manufacturing S.A. (Debiopharm, www.debiopharm.com), a Swiss-based global biopharmaceutical company aiming to cure cancer an...

April 28, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close